From enabling more sustainable practices, to solving supply chain issues and inspiring creativity, here’s how biotech is ...

Automated TCR-T production streamlines personalized immunotherapy, reducing patient burden and improving engineered T cell quality.

Diabetes goes beyond just glucose control, and recent advancements in research are enhancing drug development for the disease.

With demand for biological indicator vials on a clear growth trajectory, the months ahead promise to reshape the landscape.

Seoul has secured a $50 million investment commitment through a memorandum of understanding with a major Chinese health care ...